An Isotype-specific Activator of Major Histocompatibility Complex (MHC) Class II Genes That Is Independent of Class II Transactivator

Por Douhan, John, Lieberson, Rebecca, Knoll, Joan H.M., Zhou, Hong, Glimcher, Laurie H.
Publicado em 1997

A roadmap to evaluate the proteome-wide selectivity of covalent kinase inhibitors

Por Lanning, Bryan R., Whitby, Landon R., Dix, Melissa M., Douhan, John, Gilbert, Adam M., Hett, Erik C., Johnson, Theodore O., Joslyn, Chris, Kath, John C., Niessen, Sherry, Roberts, Lee R., Schnute, Mark E., Wang, Chu, Hulce, Jonathan J., Wei, Baoxian, Whiteley, Laurence O., Hayward, Matthew M., Cravatt, Benjamin F.
Publicado em 2014

Aminopyrazole Carboxamide Bruton’s Tyrosine Kinase Inhibitors. Irreversible to Reversible Covalent Reactive Group Tuning

Por Schnute, Mark E., Benoit, Stephen E., Buchler, Ingrid P., Caspers, Nicole, Grapperhaus, Margaret L., Han, Seungil, Hotchandani, Rajeev, Huang, Nelson, Hughes, Robert O., Juba, Brian M., Kim, Kyung-Hee, Liu, Erica, McCarthy, Erin, Messing, Dean, Miyashiro, Joy S., Mohan, Shashi, O’Connell, Thomas N., Ohren, Jeffrey F., Parikh, Mihir D., Schmidt, Michelle, Selness, Shaun R., Springer, John R., Thanabal, Venkataraman, Trujillo, John I., Walker, Daniel P., Wan, Zhao-Kui, Withka, Jane M., Wittwer, Arthur J., Wood, Nancy L., Xing, Li, Zapf, Christoph W., Douhan, John
Publicado no ACS Med Chem Lett (2018)